USPH.NYSEU S Physical Therapy INC /NV

Form 4: U.S. Physical Therapy Co-Chief Operations Officer Eric Williams Sells 2,500 Shares

Sentiment:

SEC Form 4

📋All filings for U S Physical Therapy INC /NV
🔒Login to Follow

Eric Joseph Williams, Co-Chief Operations Officer of U.S. Physical Therapy, sold 2,500 shares of common stock at a weighted average price of $104.22 on May 10, 2024.

Summary

  • On May 10, 2024, Eric Joseph Williams, Co-Chief Operations Officer of U.S. Physical Therapy Inc., sold 2,500 shares of the company's common stock.
  • The shares were sold at a weighted average price of $104.22, with individual transaction prices ranging from $104.00 to $105.00.
  • Following the transaction, Williams directly owns 16,814 shares of U.S. Physical Therapy Inc.
  • This includes 14,622 shares granted as restricted stock under the company's Amended and Restated 2003 Stock Incentive Plan, which vest in installments through January 1, 2028, contingent upon continued employment.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive. The sentiment is neutral as it simply reports a transaction without expressing any positive or negative outlook.

Industry Context

Executive stock sales are a common occurrence and are often scrutinized by investors for insights into management's perspective on the company's valuation and future prospects. However, without additional context, it's difficult to determine the specific reasons behind this particular sale.

Comparison to Industry Standards

  • Executive compensation and stock ownership structures vary across the healthcare and physical therapy industry.
  • Comparing Williams' stock ownership and trading activity to peers at companies like ATI Physical Therapy or Select Medical Holdings could provide a benchmark, but requires access to their executive compensation disclosures and Form 4 filings.
  • Generally, stock sales are evaluated in the context of overall compensation packages, company performance, and individual financial planning.

Stakeholder Impact

  • The stock sale could have a minor impact on shareholders if it creates downward pressure on the stock price, although a sale of 2,500 shares is unlikely to have a significant effect.
  • The sale does not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
05/10/2024Date of the stock sale transaction.
05/14/2024Date of Form 4 filing.
07/01/2024First vesting date for 1,408 restricted shares.
10/01/2024Second vesting date for 1,408 restricted shares.
01/01/2025Third vesting date for 1,409 restricted shares.
04/01/2025Fourth vesting date for 1,408 restricted shares.
07/01/2025Fifth vesting date for 1,414 restricted shares.
10/01/2025Sixth vesting date for 1,130 restricted shares.
01/01/2026Seventh vesting date for 1,139 restricted shares.
04/01/2026Eighth vesting date for 818 restricted shares.
07/01/2026Ninth vesting date for 818 restricted shares.
10/01/2026Tenth vesting date for 818 restricted shares.
01/01/2027Eleventh vesting date for 827 restricted shares.
04/01/2027Twelfth vesting date for 506 restricted shares.
07/01/2027Thirteenth vesting date for 506 restricted shares.
10/01/2027Fourteenth vesting date for 506 restricted shares.
01/01/2028Fifteenth vesting date for 507 restricted shares.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.